medicationPrescription only (US)Metronidazole (oral and vaginal formulations) is FDA-approved for bacterial vaginosis, trichomoniasis, and various anaerobic infectionsThe cited trials studied recurrence-prevention strategies (partner treatment, vaginal probiotic) layered on top of standard metronidazole or an alternative antimicrobial as the active comparator
MetronidazoleBenefits, Dosage & Interactions
Also known as: Flagyl
Metronidazole is an antibiotic and antiprotozoal medication used to treat a wide variety of infections caused by anaerobic bacteria and certain parasites. It is commonly sold under the brand name Flagyl. It is typically taken with a meal. The reported plasma half-life is about 8 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 3 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
3 human randomized trials and regulatory approval on file.
Plasma half-life
~8 h
Typical timing
with meal
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Reported for Metronidazole in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Metronidazole entry is written from. Each number matches an inline marker above.
- [1]Male-Partner Treatment to Prevent Recurrence of Bacterial VaginosisVodstrcil LA, Plummer EL, Fairley CK, Hocking JS, Law MG, Petoumenos K · The New England Journal of Medicine · 2025 · Peer-reviewed · PMID 40043236
- [2]Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial VaginosisCohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H · The New England Journal of Medicine · 2020 · Peer-reviewed · PMID 32402161
- [3]Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical TrialRaba G, Durkech A, Malík T, Bassfeld D, Grob P, Hurtado-Chong A · JAMA Network Open · 2024 · Peer-reviewed · PMID 38696172
How to track Metronidazole doses
Tracking Metronidazole well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Metronidazole with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is with_meal. Take it with food, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Metronidazole through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 8 h, effects and timing shifts show up over days rather than instantly. Review Metronidazole alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day and whether it was taken with food
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Metronidazole dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Metronidazole?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Metronidazole is an antibiotic and antiprotozoal medication used to treat a wide variety of infections caused by anaerobic bacteria and certain parasites. It is commonly sold under the brand name Flagyl.
It is available in several forms, including oral tablets, oral capsules, topical cream, topical gel, lotion, and intravenous injection. The choice of formulation depends on the type and location of the infection being treated. Metronidazole works by interfering with the DNA of susceptible organisms, ultimately leading to their death.
Metronidazole is a prescription medication, meaning it must be prescribed and monitored by a licensed healthcare professional. It is important to complete the full course of treatment, even if symptoms improve, to ensure the infection is fully eradicated and to prevent the development of antibiotic resistance. (MedlinePlus, DrugBank)
What does the research say about Metronidazole?
Tap a section to expand.
Metronidazole is a prodrug, meaning it is inactive until it is metabolized within the body. Its antimicrobial activity is primarily due to its ability to be selectively taken up by anaerobic bacteria and certain parasitic protozoa. Once inside these organisms, metronidazole is reduced by specific enzymes to form highly reactive nitro radical anions.
These radical anions interact with the DNA of the microorganism, causing damage to the DNA structure, including strand breakage and inhibition of DNA synthesis. This DNA damage is lethal to the cell, leading to the eradication of the infection. Because human cells lack the specific enzymes required to reduce metronidazole in this manner, it has selective toxicity towards anaerobic microorganisms and parasites while largely sparing human cells. This mechanism of action makes it effective against a broad spectrum of anaerobic bacteria, including *Bacteroides fragilis* and *Clostridium difficile*, as well as protozoa such as *Giardia lamblia* and *Trichomonas vaginalis*. (DrugBank, PubChem)
Source for this section: Sources for How does Metronidazole work?: Jumps to this entry in the sources and references list at the end of the page.
Metronidazole is widely used due to its effectiveness against a variety of serious infections. Its benefits stem from its ability to target specific anaerobic bacteria and parasitic protozoa that are often difficult to treat with other antibiotics.
Common conditions treated with metronidazole include:
* **Bacterial vaginosis:** An infection of the vagina caused by an overgrowth of certain bacteria.
* **Trichomoniasis:** A sexually transmitted infection caused by a parasite.
* **Giardiasis:** An intestinal infection caused by a parasite, often acquired through contaminated water.
* **Amebiasis:** An infection of the intestines and sometimes other organs, caused by a parasite.
* **Clostridioides difficile infection (CDI):** A severe type of diarrhea caused by bacteria, often occurring after antibiotic use.
* **Anaerobic bacterial infections:** Such as those affecting the gastrointestinal tract, skin, bones, joints, and respiratory system. This includes intra-abdominal infections, pelvic inflammatory disease, and certain skin and soft tissue infections.
* **Rosacea:** A chronic skin condition, where topical formulations of metronidazole are used to reduce inflammation and redness.
Metronidazole is often a first-line treatment for many of these conditions due to its established efficacy and relatively well-understood safety profile. (MedlinePlus, Mayo Clinic)
The efficacy of metronidazole is well-supported by extensive clinical use and numerous studies. For example, a Cochrane review on antibiotics for *Clostridium difficile*-associated diarrhea in adults concluded that metronidazole is an effective treatment, though sometimes less effective than vancomycin in severe cases. This review pooled data from multiple randomized controlled trials.
Studies published in medical journals have consistently demonstrated its effectiveness in treating bacterial vaginosis, trichomoniasis, and giardiasis. For instance, an NIH-funded study (available through PubMed) confirmed the effectiveness of metronidazole in treating bacterial vaginosis. Its use in prophylaxis against postoperative infections in colorectal surgery and other procedures where anaerobic bacteria are a concern is also well-documented by clinical guidelines and research.
Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved metronidazole for various indications based on robust clinical trial data demonstrating its safety and efficacy. The FDA label for metronidazole provides comprehensive evidence supporting its approved uses. (Cochrane, FDA label, EMA SmPC)
Like all medications, metronidazole can cause side effects, although not everyone experiences them. The severity and type of side effects can vary depending on the dosage, duration of treatment, and individual patient factors.
Common side effects include:
* Nausea, vomiting, diarrhea, or stomach cramps
* Metallic taste in the mouth (very common)
* Headache
* Dizziness
* Loss of appetite
* Darkening of urine (harmless)
Less common but more serious side effects may include:
* **Peripheral neuropathy:** Numbness, tingling, or weakness in the hands or feet (usually with prolonged use or high doses)
* **Seizures:** Though rare, this is a serious neurological side effect.
* **Aseptic meningitis**
* **Optic neuropathy** (vision problems)
* **Pancreatitis**
* **Severe allergic reactions:** Rash, itching, swelling, severe dizziness, trouble breathing.
* **Thrombocytopenia** (low platelet count) or **Leukopenia** (low white blood cell count)
* **Furry tongue, glossitis, stomatitis**
Contact your doctor immediately if you experience any severe or persistent side effects. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Several important warnings are associated with metronidazole use:
* **Neurological Effects:** Metronidazole has been associated with neurological adverse reactions including seizures and peripheral neuropathy. These symptoms may occur with prolonged use or high doses. If neurological symptoms develop, treatment should be re-evaluated. (FDA label)
* **Carcinogenicity:** Studies in rodents have shown metronidazole to be carcinogenic. While the relevance of these findings to humans is not fully established, it is a concern, and metronidazole should be used with caution and only when clearly indicated. (FDA label)
* **Liver Impairment:** Patients with severe hepatic impairment metabolize metronidazole slowly, which can lead to accumulation of the drug and its metabolites. Dosage adjustment may be necessary in these patients. (EMA SmPC)
* **Blood Dyscrasias:** Leukopenia and neutropenia have been reported during metronidazole therapy, particularly with prolonged use. Complete blood count monitoring is advised if treatment extends beyond 10 days. (FDA label)
* **Superinfection:** As with other antibiotics, prolonged use of metronidazole may result in the overgrowth of non-susceptible organisms, including fungi, leading to superinfections. C. difficile-associated diarrhea can occur after metronidazole administration. (MedlinePlus)
* **Pregnancy and Breastfeeding:** Metronidazole crosses the placental barrier. While studies to date have not shown a consistent pattern of birth defects, it is generally recommended to avoid its use during the first trimester of pregnancy unless clearly necessary. It is excreted in breast milk, and breastfeeding may need to be temporarily suspended or an alternative feeding method considered. (FDA label)
* **Alcohol Interaction:** A severe disulfiram-like reaction can occur if alcohol is consumed during or within 3 days of stopping metronidazole. Symptoms include flushing, headache, nausea, vomiting, and abdominal cramps. Patients should be warned to avoid all alcohol-containing products. (PubChem)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Metronidazole is contraindicated in specific situations to prevent adverse and potentially serious reactions:
* **Hypersensitivity:** Individuals with a known allergy or hypersensitivity to metronidazole or other nitroimidazole derivatives should not use this medication. Allergic reactions can range from skin rashes to severe anaphylaxis.
* **First Trimester of Pregnancy:** Generally, metronidazole is contraindicated during the first trimester of pregnancy due to concerns regarding potential developmental effects, unless the benefit clearly outweighs the risk. Definitive human studies are limited, but caution is advised.
* **Concurrent Alcohol Use:** The consumption of alcohol or propionyl alcohol-containing products during metronidazole treatment and for at least 3 days after discontinuation is a strict contraindication due to the risk of a severe disulfiram-like reaction (e.g., nausea, vomiting, flushing, headache).
Additionally, caution should be exercised in patients with certain pre-existing conditions, including severe liver disease, central nervous system disorders (e.g., epilepsy, a history of seizure disorders), and blood dyscrasias, where the risks may outweigh benefits or require significant dose adjustments and careful monitoring. (FDA label, EMA SmPC)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Metronidazole has several significant drug-drug interactions that can alter its effectiveness or increase the risk of adverse effects. It is crucial to inform your clinician about all medications, supplements, and herbal products you are taking.
Key substances to avoid or use with extreme caution while on metronidazole include:
* **Alcohol:** As mentioned, consuming alcohol during metronidazole treatment and for at least 3 days after stopping can cause a disulfiram-like reaction with symptoms such as nausea, vomiting, flushing, and headaches. This includes alcohol in medications, mouthwashes, and even some cosmetic products.
* **Warfarin (and other oral anticoagulants):** Metronidazole can enhance the anticoagulant effect of warfarin, increasing the risk of bleeding. Close monitoring of International Normalized Ratio (INR) is necessary, and dose adjustment of the anticoagulant may be required.
* **Lithium:** Metronidazole can increase plasma lithium concentrations, leading to lithium toxicity. Monitoring of plasma lithium levels is essential.
* **Disulfiram:** Concomitant use with disulfiram may result in psychotic reactions, including confusion and hallucinations. This combination should be avoided.
* **Phenobarbital and Phenytoin:** These anticonvulsants can accelerate the metabolism of metronidazole, reducing its effectiveness. Conversely, metronidazole can inhibit the metabolism of phenytoin, increasing its levels and potential toxicity.
* **Cimetidine:** Cimetidine can decrease the metabolism of metronidazole, potentially increasing its plasma concentration and the risk of side effects.
* **Busulfan:** Metronidazole may increase plasma concentrations of busulfan, increasing the risk of busulfan toxicity.
Always discuss all current medications with your healthcare provider to avoid dangerous interactions. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Metronidazole is typically taken "with_meal" to help reduce stomach upset and nausea, which are common side effects. The specific timing and frequency will be directed by a licensed clinician, depending on the infection being treated, its severity, and the patient's individual needs. For example, some regimens may involve taking it once daily, while others may require two or three times a day.
It is crucial to follow the prescribed dosing schedule exactly and to complete the entire course of medication, even if symptoms improve before the medication is finished. Stopping treatment early can lead to a recurrence of the infection and contribute to antibiotic resistance.
Topical forms (creams, gels) are applied as directed by the clinician, usually once or twice daily, to the affected skin area.
Source for this section: Sources for When should you take Metronidazole?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Metronidazole?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
Frequently asked questions about Metronidazole
Metronidazole is a medication. It is also known as Flagyl. What follows is drawn from peer-reviewed literature indexed on PubMed, FDA label text where a label exists, and NIH reference records.
Metronidazole is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Metronidazole, it is typically taken with a meal, it is usually taken with food, and its approximate half-life is 8 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
Metronidazole carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
Metronidazole is a medication, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Metronidazole is usually taken with a meal, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 8 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Metronidazole with no sign-up.
Combining a medication like Metronidazole with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Metronidazole: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 8 hours, once-daily dosing is the usual pattern for Metronidazole. It is typically taken with a meal. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
With a plasma half-life near 8 hours, a single missed dose of Metronidazole usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Metronidazole the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Metronidazole?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Metronidazole-induced encephalopathy: a systematic review(opens PubMed in a new tab)J Neurol · 2020 · PMID 30536109 · https://pubmed.ncbi.nlm.nih.gov/30536109/
- 2.Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories.(opens PubMed in a new tab)Chemotherapy · 1980 · PMID 7389423 · https://pubmed.ncbi.nlm.nih.gov/7389423/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 4173(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/4173
Verify at
Publisher search links for Metronidazole. These are places to check the information — they are not citations, so they are not numbered.
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Metronidazole?
Plain-text summary, safe to quote verbatim:
Metronidazole is an antibiotic and antiprotozoal medication used to treat a wide variety of infections caused by anaerobic bacteria and certain parasites. It is commonly sold under the brand name Flagyl. It is typically taken with a meal. The reported plasma half-life is about 8 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/metronidazole
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Metronidazole — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/metronidazole
What compounds are similar to Metronidazole?
Others in the medication category or studied for the same goals.